Search
EHA’s advocacy for hematology continues
The EHA Board has recently approved five position papers which formulate EHA’s key lobbying priorities:
Support for hematology research in Horizon 2020 (and future EU research funding programs)
Access to treatment for patients with blood disorders
EU collaboration to reduce the prices…
Young researchers to benefit from EHA training and mentoring
Participation in EHA-CRTH will allow these researchers to fine-tune the skills and knowledge required to successfully design, run and complete clinical trials.
Read moreEuropean Reference Networks, a unique opportunity to take collaboration and patient care in hematology to the next level, was a core topic at EHA 2016
On Saturday 11 June, a session in the Patient Advocacy Track focused on the emerging European Reference Networks (ERNs).
Read moreEHA Award winners put in the spotlight in Copenhagen
The EHA-José Carreras Non-Clinical Junior Fellowship is made possible with the support of the German José Carreras Foundation.
Read moreSurvey Monitoring H2020 – your input is needed!
We need your input to improve Horizon 2020 and the next Research and Innovation Framework Programme of the European Union.
Read moreTraining vital for new era of patient-centric healthcare
Christine Chomienne, president of the European Hematology Association (EHA), was speaking at the third annual conference of the European Alliance for Personalised Medicine (EAPM) – a Brussels-based organization that brings together stakeholders from academia, through research,…
Read moreJesus San Miguel presents the Ham-Wasserman Lecture at the 2014 ASH Annual Meeting
Professor San Miguel is a member of the Advisory board of the International Myeloma Foundation and the Multiple Myeloma Research Foundation.
Read moreAnnouncement: The award winners of the prestigious EHA-ASH Translational Research in Hematology Training Award are selected
The winners of the TRTH 2015 Awards are:
Name
Nationality
Name
Nationality
Ileana Antony-Debre
French
Jean-Baptiste Micol
French
Pavan Bachireddy
American
Christopher Ott
American
Lucile Couronné
French
Carsten Riether
German
Moniek de Witte
Dutch
Anindita Roy
British
Ammon Fager
American
Melody Smith
American
Gillian Horne
British
Zuzana Tothova
Slovakian
Moonjung Jung
South Korea
Marcin Wlodarski
Polish
Jonas Samuel Jutzi
Swiss - German
Yuh-Ying Yeh
Taiwanese
Milka Koupenova-Zamor
American - Bulgarian
Sasan Zandi
Iranian
Marwan Kwok
British
Patricia Maiso
Spain
Are you interested in joining the…
First Horizon 2020 Work Programme update – budget, and launch of FTI and innovation prizes
Click here for the PDF.
Read moreABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL.
Chronic Lymphocytic Leukaemia (CLL) is the most common leukemia in adults in the Western world and is diagnosed in approximately 5 persons per 100,000 population per year.
Read more